Growth Factor

Type: Keyphrase
Name: Growth Factor
First reported 1 hour ago - Updated 1 hour ago - 1 reports

PRP for Hair Loss

Deck:Using PRP nonsurgically to stimulate hair growth in early androgenetic alopecia.Byline:By Garry R. Lee, MD, and Gordon H. Sasaki, MD, FACSMain Image:Your patients who are losing their hair may be enticed by the Platelet-Rich Plasma (PRP) concept. ... [Published MedEsthetics Magazine - 1 hour ago]
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Method and system for isolated hole detection and growth in a document image

A method for detecting and growing isolated holes in a document image having a plurality of pixels is provided. The method includes isolating the pixels of the image to form a plurality of windows, each window having a target pixel; identifying a hole ... [Published Free Patents Online - 3 hours ago]
Entities: Growth Factor
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Inhibitors of STAT3 and uses thereof

Compounds which inhibit the activity of signal transducer and activator of transcription 3 (STAT3) are provided together with methods of making and using the same. The compounds are designed to bind to the SH2 domain of STAT3, preventing STAT3 from binding ... [Published Free Patents Online - 12 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors

A vaccine composition for therapeutic use thereof on cancer patients includes a chemical conjugate of human recombining Epidermic Growth Factor (hrEGF) and a combining protein P64k for performing a conjugation reaction which produces said chemical conjugate ... [Published Free Patents Online - 12 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Methods for culturing undifferentiated cells using sustained release compositions

Methods for culturing undifferentiated mammalian cells, such as stem and progenitor cells, are provided. The methods involve incubating the cell in the presence of a sustained release composition containing at least one growth factor, wherein the sustained ... [Published Free Patents Online - 12 hours ago]
Entities: Growth Factor
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Blood Test Offers Specific Treatment for Ovarian Cancer

A new blood test has been developed allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment.Ovarian cancer is the fourth most common cause of female cancer-related death, accounting for thousands of lives ... [Published Lab Medica - Sep 22 2014]
First reported Sep 21 2014 - Updated Sep 21 2014 - 1 reports

Want healthy skin? Limit these 5 types of foods

Glowing, radiant, clear — those are the words you want to use to describe your skin, your body’s largest organ. But what do you do when the words that come to mind are tired, stiff, irritated or dry?There are plenty of foods — rich in vitamin A, vitamin ... [Published News.am - Sep 21 2014]
Entities: Diet, Insulin, Collagen, Sodium
First reported Sep 20 2014 - Updated Sep 20 2014 - 1 reports

AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without ...

Inflammation is a key etiologic component in atherogenesis and transforming growth factor beta 1 (TGF?1) is a well known anti-inflammatory cytokine which potentially might be used to limit it. Yet TGF?1 is pleiomorphic, causing fibrosis, cell taxis, and ... [Published 7thSpace - Sep 20 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Eylea, Lucentis Equally Likely to Be Covered on Commercial and Medicare Advantage Plans for Wet AMD

Pricing will be key to formulary acceptance of Fovista and abicipar pegolAflibercept (Eylea, Regeneron), the most recently launched antivascular endothelial growth factor (VEGF) agent for wet age-related macular degeneration (AMD), is as likely to be ... [Published PT Community - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time

ROCKLAND, Massachusetts The first grants awarded to coincide with the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting Investment supports innovative projects for the advancement of science and medical research in the field of growth ... [Published Bio-Medicine - Sep 19 2014]
Entities: EMD Serono, Gaala, NICHD
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Jasper County Council passes budget

JASPER COUNTY — The Jasper County Council held a public hearing Tuesday and voted to approve the 2015 county budget that will then be sent to Indianapolis for approval. The county’s budget for 2015 is over $33.5 million. There were no comments from the ... [Published Watseka Times Republic - Sep 18 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Environmental Particulate (PM2.5) Augments Stiffness-Induced Alveolar Epithelial Cell Mechanoactivation of Transforming Growth Factor Beta

by Marilyn M. Dysart, Boris R. Galvis, Armistead G. Russell, Thomas H. BarkerDysfunctional pulmonary homeostasis and repair, including diseases such as pulmonary fibrosis (PF), chronic obstructive pulmonary disease (COPD), and tumorigenesis have been ... [Published Plosone.org - Sep 16 2014]

Quotes

Author: Kevin Mackie is from Calgary, Alberta , . Canada . He has a B Sc. in I Computer Science from the " University of Calgary and has worked in the Oil and Gas Pipeline SCADA Industry since i992. He is currently a SCADA Product Manager in Schneider Electrics Oil and Gas Segment."
"With the standard treatment, the cancer disappeared in 46 percent. With the addition, it went up to 60 percent" Sikov said
...This suggests that, "Some patients may have an immune defect that's associated with impaired clearance of antigen, that would be manifest as low cytokine values. This may result in a higher antigen load when they start ART they have a higher risk of IRIS" said Bisson
Ingmar Hoerr, co-founder and CEO of CureVac GmbH commented: "This collaboration is extremely relevant for CureVac because, as a biotech enterprise, we rely on collaboration with strong partners for the clinical development and commercialisation of our compounds. Cancer immunotherapy represents one of the biggest innovations in cancer treatment of recent times and we are delighted to now be working with Boehringer Ingelheim. The out-licensing and clinical development of our promising therapeutic vaccine CV9202 represents the logical next step in developing this novel treatment for cancer patients and the significant commitment from Boehringer Ingelheim underscores the relevance of the mRNA technology."

More Content

All (588) | News (530) | Reports (0) | Blogs (54) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
PRP for Hair Loss [Published MedEsthetics Magazine - 1 hour ago]
Characterizing Performance of Enterprise Pipeli... [Published Insurance News Net - 1 hour ago]
The Effects of Harvesting Media on Biological C... [Published Plosone.org - 1 hour ago]
Health Check: Treatment of triple-negative brea... [Published TurnTo10.com - 1 hour ago]
Transcriptomic Characterization of C57BL/6 Mous... [Published Plosone.org - 2 hours ago]
Method and system for isolated hole detection a... [Published Free Patents Online - 3 hours ago]
ICAAC 2014: IRIS and Risk of Early Death Among ... [Published HIV and Hepatitis.com - 5 hours ago]
BioMarin to Attend Upcoming Investor Conferences [Published Street Sweeper - 8 hours ago]
MicroRNA-409-3p Functions as a Tumor Suppressor... [Published Sexual Development - 8 hours ago]
Inactivation of AMPK Mediates High Phosphate-In... [Published Sexual Development - 8 hours ago]
Sodium Iodate Influences the Apoptosis, Prolife... [Published Sexual Development - 8 hours ago]
Boehringer Ingelheim and CureVac collaborate fo... [Published Individual.com - 11 hours ago]
Method for making a homogenous vaccine composit... [Published Free Patents Online - 12 hours ago]
Inhibitors of STAT3 and uses thereof [Published Free Patents Online - 12 hours ago]
Methods for culturing undifferentiated cells us... [Published Free Patents Online - 12 hours ago]
Regeneron’s EYLEA Gets Japanese Ministry’s Appr... [Published Bidness Etc - 23 hours ago]
Eye treatment of the future: drugs and other ap... [Published Optician Online - Sep 22 2014]
FibroGen, Inc.Announces One-Year Data Supportin... [Published BioSpace - Sep 22 2014]
FGF23 Deficiency Leads to Mixed Hearing Loss an... [Published Plosone.org - Sep 22 2014]
Lost protein could prevent hardening of the art... [Published MyScience - Sep 22 2014]
Boehringer Ingelheim and CureVac link on lung c... [Published Pharma Letter - Sep 22 2014]
Bayer Receives Approval for EYLEA for the Treat... [Published FirstWord Pharma - Sep 22 2014]
Blood Test Offers Specific Treatment for Ovaria... [Published Lab Medica - Sep 22 2014]
Recombinant vectors [Published PharmCast - Sep 21 2014]
Want healthy skin? Limit these 5 types of foods [Published News.am - Sep 21 2014]
FibroGen Announces One-Year Data Supporting the... [Published BusinessWeek - Sep 20 2014]
India Catheterization Laboratory Market Outlook... [Published PR.com Press Releases - Sep 20 2014]
AAV2/8-hSMAD3 gene delivery attenuates aortic a... [Published 7thSpace - Sep 20 2014]
Characterization of ductal carcinoma in situ ce... [Published 7thSpace - Sep 20 2014]
In Vivo Evidence for Platelet-Induced Physiolog... [Published Plosone.org - Sep 20 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
India Catheterization Laboratory Market Outlook... [Published PR.com Press Releases - Sep 20 2014]
New York, NY, September 20, 2014 --( PR.com )-- Global market intelligence firm, Netscribes, Inc. released its latest report on the ‘Catheterization Laboratory Market in India 2014’. The constant growth in the number of patients suffering from cardiovascular ...
Regeneron's Eylea and Genentech's Lucentis Are ... [Published PR Newswire: Health - Sep 18 2014]
BURLINGTON, Mass., Sept. 18, 2014 /PRNewswire/ -- Decision Resources Group finds that Regeneron's Eylea, the most recently launched anti-vascular endothelial growth factor (VEGF) agent for wet AMD, is equally likely to be covered on commercial and ...
ARCH Ventures leads $20 mln Series A funding in... [Published PE Hub Blog - Sep 15 2014]
ARCH Venture Partners has led a $20 million Series A funding in Scholar Rock , a biopharmaceutical company. Other participants in the funding include founding investors Polaris Partners and Timothy Springer , as well as new investors EcoR1 Capital ...
Blood Test for VEGF-A, TGF-B1 Prior to Treatmen... [Published Marketwire - Breaking News Releases - Sep 14 2014]
SAN FRANCISCO, CA--(Marketwired - September 14, 2014) - A blood test may be beneficial in indicating neoadjuvant treatment regimens for patients with esophageal squamous cell carcinoma (ESCC), according to research presented today at the American Society ...
Growth Factors Found in Breast Milk may Protect... [Published theCSRfeed - Sep 09 2014]
Studies suggest that ErbB4 receptor activation may be a novel therapeutic avenue for intestinal diseases involving epithelial cell death, according to research published in The American Journal of Pathology SOURCE: Elsevier DESCRIPTION: PHILADELPHIA, ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Amarantus CSO to Present on PhenoGuard Data at ... [Published GlobeNewswire: Acquisitions News - Apr 28 2014]
Blueprint Medicines Presents Positive Data on F... [Published GlobeNewswire: Acquisitions News - Apr 07 2014]
Alpha and Omega Gene Therapy Eye Cream's Scient... [Published PR Newswire - Dec 19 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.